TARCEVA*
- Erlotinib hydrochloride - (Tarceva)- @ -(May 2013)-Epidermal Growth Factor Receptor Inhibitors - Antineoplastic Agents
Compositions:
Erlotinib -mg,
List of Related Indications:
Erlotinib -mg,
- Metastatic Non-small Cell Lung Cancer (NSCLC)
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit |